Moneycontrol PRO

you are here: HomeNewsBusinessEarningsElder Pharma sees 21% growth in domestic formulations ahead

SHOW NAMES

Trending Topics

SBI Q1 Results Manappuram Finance Q1 Results Tata Motors Q1 results Titan Q1 Preview SBI Q1 Preview

business

Elder Pharma sees 21% growth in domestic formulations ahead

In an interview with CNBC-TV18, Alok Saxena, Director (International), Elder Pharmaceuticals spoke about the performance of the company. The company is expecting its domestic formulation business to report growth of 20-25% ahead.

first published: May 10, 2011 04:31 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347